MedTrace Logo

Neurostimulation for Opiate Withdrawal in the PICU

NCT03975192 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2020-10-26

No results posted yet for this study

Summary

This is a prospective pilot study to investigate the effects of Percutaneous Electrical Nerve Field Stimulation (PENFS) on symptoms of opioid withdrawal in pediatric patients in the intensive care unit.

Conditions

  • Opiate Withdrawal Syndrome

Interventions

DEVICE

Percutaneous Electrical Nerve Field Stimulation

Placement of the PENFS device immediately following the last scheduled opiate dose in the PICU with active stimulation for 120 hours.

Sponsors & Collaborators

  • Medical College of Wisconsin

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2020-10-22
Completion
2020-10-22
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03975192 on ClinicalTrials.gov